Hillsdale Investment Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.47K | Buy |
800
+50
| +7% | +$405 | ﹤0.01% | 570 |
|
|
2025
Q1 | $6.29K | Buy |
+750
| New | +$6.29K | ﹤0.01% | 540 |
|
|
2024
Q2 | – | Sell |
-699,719
| Closed | -$4.24M | – | 580 |
|
|
2024
Q1 | $4.24M | Buy |
699,719
+115,100
| +20% | +$698K | 0.34% | 108 |
|
|
2023
Q4 | $3.55M | Buy |
584,619
+541,000
| +1,240% | +$3.28M | 0.29% | 135 |
|
|
2023
Q3 | $184K | Buy |
+43,619
| New | +$184K | 0.02% | 352 |
|
|
2022
Q4 | – | Sell |
-861,716
| Closed | -$1.74M | – | 550 |
|
|
2022
Q3 | $1.74M | Hold |
861,716
| – | – | 0.16% | 155 |
|
|
2022
Q2 | $2.74M | Hold |
861,716
| – | – | 0.22% | 147 |
|
|
2022
Q1 | $3.59M | Sell |
861,716
-8,200
| -0.9% | -$34.2K | 0.23% | 148 |
|
|
2021
Q4 | $4.17M | Sell |
869,916
-2,600
| -0.3% | -$12.5K | 0.28% | 125 |
|
|
2021
Q3 | $4.66M | Buy |
872,516
+85,700
| +11% | +$458K | 0.36% | 87 |
|
|
2021
Q2 | $4.03M | Buy |
786,816
+175,616
| +29% | +$899K | 0.32% | 110 |
|
|
2021
Q1 | $4.11M | Buy |
+611,200
| New | +$4.11M | 0.34% | 97 |
|